IRMA YEHUDA: Open Payments
NPI 1871680884 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$341 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $60 · 2025 $341
Food & beverage: $341
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $101 |
| Astellas Pharma US Inc | 2 | $63 |
| Exeltis, USA Inc. | 2 | $49 |
| Sage Therapeutics, LLC | 1 | $28 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Evofem Biosciences, Inc. | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| MILLICENT US INC | 1 | $16 |
| CooperSurgical, Inc. | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $4 |
Products named: MYFEMBREE, Veozah, SLYND, ZURZUVAE, THINPREP 2000 PROCESSOR, Phexxi, ACCRUFER, INTRAROSA.
Industry payments across PA — which companies pay providers there.
